Three humans, eight AI team members, one product. The multi-agent collaboration pattern Stark Insider readers have been ...
Zaya1-8B is a huge shift in LLMs, and the results are impressive.
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Anthropic’s Project Glasswing, an industry-wide initiative built around the restricted-access Claude Mythos Preview model, is ...
It is common understanding that as quantum computing gets its feet under itself, it will work hand-in-hand with classical ...
The business became more agile and IT became less of a friction point, but the operating model of the enterprise largely ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
We examine how AI is changing the future of work — and how, in many ways, that future is already here. Every tech company you can think of is jumping on the generative AI bandwagon and touting new ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...